Figure 2.Age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) by province of China, 2019. (A) ASIR of HL, (B) ASMR of HL, (C) ASIR of NHL, (D) ASMR of NHL.
Figure 2 — Burden of lymphoma in China, 1990−2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019 | Aging
